ISPC

distress 6/10 · elevated risk

$2.27+1%today-97% from 52w high

ispecimen.com7 employeesFounded 2009Woburn, MADiagnostics & Research

Revenue

pre-revenue

Liquidity

$9M

Runway

1.4 yrs

Shares 1y

-74%

Price & events

-85.3% over 6M

CatalystRating changeDilutionFinancingdashed = today

+0.9%

+2.8%

-10.6%

-65.0%

-85.2%

-94.9%

-99.0%

-99.9%

-100.0%

All

Overview

Market Cap: $3.26M
Volume: 3.16K
52 Week Range: $2.10 – $78.00
Total Shares: 1.44M
Float Shares: 1.44M
Short %: 10.90%
% Held by Insiders: 0.07%
% Held by Institutions: 0.92%
RVOL: 0.03x
Beta: 1.63

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 1,437,157 · 3 offerings/1y · 2 PIPEs

2026-07-17S-1/Ashelf_registration
2026-07-06S-1/Ashelf_registration
2026-06-24S-1shelf_registration
2026-06-17EFFECTshelf_effective
2026-06-04S-3shelf_registration
2026-05-138-Kprivate_placement
2026-02-03424B3offering

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified